NLRP12 and colitis: These observations would be consistent with those of others using experimental models of colitis and colitis-associated colon cancer (CAC) [20, 25, 33, 49], where an inhibitory role for Nlrp12 is also involved in suppression of BM-derived macrophage recruitment and cytokine/chemokine expression.